Pages that link to "Template:ReferenceData"

The following pages link to Template:ReferenceData:

Displaying 50 items.

• Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 15 (7) - (10) (transclusion) (← links)
• Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 16 (transclusion) (← links)
• Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 17 (transclusion) (← links)
• Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 18 (transclusion) (← links)
• Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 19 - 20 (transclusion) (← links)
• Reference:GBR The Medical Devices Regulations 2002 11-Feb-2021 Article 16 (1) - (3) (transclusion) (← links)
• Reference:GBR Directive 93/42/EEC 11-Oct-2007 Annex VIII 1. ; 2. (transclusion) (← links)
• Reference:GBR Directive 93/42/EEC 11-Oct-2007 Article 15 1. - 4. (transclusion) (← links)
• Reference:GBR NIHR - National Institute for Health and Care Research 28-Jan-2025 - (transclusion) (← links)
• Reference:GBR IRAS - Integrated Research Application System 28-Jan-2025 IRAS (transclusion) (← links)
• Reference:USA 21 CFR Part 56 09-Apr-2025 § 56.102 (m) (transclusion) (← links)
• Reference:USA 21 CFR Part 56 09-Apr-2025 § 56.103 (transclusion) (← links)
• Reference:USA 21 CFR Part 56 09-Apr-2025 § 56.104 (transclusion) (← links)
• Reference:USA 21 CFR Part 56 09-Apr-2025 § 56.105 (transclusion) (← links)
• Reference:USA 21 CFR Part 56 09-Apr-2025 § 56.109 (transclusion) (← links)
• Reference:USA 21 CFR Part 56 09-Apr-2025 § 56.111 - §56.112 (transclusion) (← links)
• Reference:USA 45 CFR Part 46 09-Apr-2025 § 46.124 (transclusion) (← links)
• Reference:USA 21 CFR Part 312 09-Apr-2025 § 312.40 (b) (transclusion) (← links)
• Reference:USA 21 CFR Part 812 09-Apr-2025 Subpart B (transclusion) (← links)
• Reference:USA 21 CFR Part 812 09-Apr-2025 § 812.30 (transclusion) (← links)
• Reference:USA 21 CFR Part 812 09-Apr-2025 § 812.42 (transclusion) (← links)
• Reference:USA 21 CFR Part 812 09-Apr-2025 Subpart D (transclusion) (← links)
• Reference:USA 42 CFR Part 11 09-Apr-2025 § 11.4 (transclusion) (← links)
• Reference:USA 42 CFR Part 11 09-Apr-2025 § 11.6 (transclusion) (← links)
• Reference:USA 42 CFR Part 11 09-Apr-2025 § 11.8 (transclusion) (← links)
• Reference:USA 42 CFR Part 11 09-Apr-2025 § 11.24 (transclusion) (← links)
• Reference:USA 42 CFR Part 11 09-Apr-2025 § 11.64 (transclusion) (← links)
• Reference:ISO ISO 14155 - Clinical investigation of medical devices for human subjects 2020 Annex E-001 (transclusion) (← links)
• Reference:ICH ICH E6 Guideline R3 (2025) Appendix C-001 (transclusion) (← links)
• Reference:ICH ICH E6 Guideline R3 (2025) Appendix C C.2.3 (transclusion) (← links)
• Reference:EU EMA/INS/GCP/856758/ 2018 Guideline on the content, management and archiving of the clinical trial master file (paper and/or electronic) 06-Dec-2018 3 (transclusion) (← links)
• Reference:EU EMA/INS/GCP/856758/ 2018 Guideline on the content, management and archiving of the clinical trial master file (paper and/or electronic) 06-Dec-2018 3.5.2 (transclusion) (← links)
• Reference:EU EMA/INS/GCP/856758/ 2018 Guideline on the content, management and archiving of the clinical trial master file (paper and/or electronic) 06-Dec-2018 3.5.3 (transclusion) (← links)
• Reference:EU EMA/INS/GCP/856758/ 2018 Guideline on the content, management and archiving of the clinical trial master file (paper and/or electronic) 06-Dec-2018 5.1 - 5.2-001 (transclusion) (← links)
• Reference:EU Recommendations of the expert group - Risk proportionate approaches in clinical trials 25-Apr-2017 4.5 (transclusion) (← links)
• Reference:USA 21 CFR Part 312 09-Apr-2025 § 312.62 (transclusion) (← links)
• Reference:USA 21 CFR Part 312 09-Apr-2025 § 312.57-001 (transclusion) (← links)
• Reference:USA 21 CFR Part 812 09-Apr-2025 Subpart G (transclusion) (← links)
• Reference:WMA Declaration of Helsinki 2024 Paragraph 22 (transclusion) (← links)
• Reference:ICH ICH E6 Guideline R3 (2025) Appendix B (transclusion) (← links)
• Reference:ICH ICH E6 Guideline R3 (2025) II 7.4 (transclusion) (← links)
• Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 Glossary - protocol (transclusion) (← links)
• Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 2 (transclusion) (← links)
• Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 Appendix 2 (transclusion) (← links)
• Reference:WHO WHO - HANDBOOK FOR GOOD CLINICAL RESEARCH PRACTICE (GCP) 2005 Page 28-29 (transclusion) (← links)
• Reference:ISO ISO 14155 - Clinical investigation of medical devices for human subjects 2020 Annex A - CIP (transclusion) (← links)
• Reference:N.A. SPIRIT 2013 - Chan et al. 2013 - (transclusion) (← links)
• Reference:ICH ICH E8 Guideline R1 (2021) 5. (transclusion) (← links)
• Reference:EU EMA/298712/2022 - Complex clinical trials – Questions and answers 23-May-2022 Glossary (transclusion) (← links)
• Reference:EU Regulation (EU) No 520/2012 - performance of pharmacovigilance activities 20-Jun-12 Annex III 1. (transclusion) (← links)